Nuron Biotech
1 East Uwchlan Avenue
Suite 302
Exton
Pennsylvania
19341
United States
Tel: 610-968-6700
Fax: 610-968-6650
Website: http://www.nuronbiotech.com/
14 articles about Nuron Biotech
-
Nuron Biotech Announces Appointment of New Management Team Members and Provides an Update on Commercial Vaccine Meningitec™
10/17/2013
-
Nuron Biotech to Present at Biotechnology Industry Organization (BIO) Business Forum®
4/22/2013
-
Nuron Biotech Selected to Present at Future Leaders in the Biotech Industry Conference
4/2/2013
-
Nuron Biotech Receives Pennsylvania Bio's 2013 Deal of the Year Award for Advancing Bioscience Industry
3/18/2013
-
Nuron Biotech Raises $80 Million
12/20/2012
-
Nuron Biotech Buys Pfizer Inc.'s Preventive Vaccine Meningitec
12/10/2012
-
Nuron Biotech Completes Enrollment of a Pivotal Phase 3 Study for Proprietary Recombinant Human Interferon Beta-1b (NU100) in Relapsing Remitting Multiple Sclerosis
11/13/2012
-
Nuron Biotech Expands Portfolio With Exclusive, Worldwide License for an Amyloid Beta 42 DNA Vaccine Candidate for Alzheimer's Disease
4/9/2012
-
Nuron Biotech Expands Portfolio With License of Therapeutic and Prophylactic Hepatitis Vaccine Candidates
3/5/2012
-
Nuron Biotech Licenses HibTITER® Vaccine to Mitsubishi Tanabe Pharma Corporation for Japanese Market
1/13/2012
-
Nuron Biotech Exercises Option for a Licence to PolyTherics' TheraPEG™ Technology to Develop a Long-Acting Human Interferon beta-1b
12/13/2011
-
Nuron Biotech Initiates Phase 3 Study of Proprietary Recombinant Human Interferon Beta-1b (NU100) in Relapsing Remitting Multiple Sclerosis
11/1/2011
-
Nuron Biotech to Develop Long-acting Version of Proprietary Recombinant Human Interferon Beta-1b Utilizing PolyTherics’ TheraPEG(TM) PEGylation Technology
5/27/2011
-
Nuron Biotech Acquires Assets Related to HibTITER(R) Conjugate Vaccine from Wyeth
4/6/2011